Search Results

(
)

Filter by
Clear
Filter by health areas, people and populations, or solutions
Filter by EGPAF’s stories, research, resources or news

Project Brief

Building Health Systems Capacity to Manage Pediatric HIV

Published July 17, 2024

As countries work towards the UNAIDS 95-95-95 goals for HIV epidemic control, the third 95 of viral suppression becomes pivotal, especially for children and adolescents living with HIV (CALHIV). An estimated 10-20% of CALHIV have an unsuppressed viral load (VL) on their current first- or second-line antiretroviral therapy (ART)…

Topics:

Pediatric HIV

Countries:

Cameroon,

Eswatini,

Kenya,

Lesotho,

Nigeria,

Republic of the Congo,

Rwanda,

Uganda,

Zambia,

Zimbabwe

Project Brief

Building Health Systems Capacity Reaching HIV Epidemic Viral Suppression Targets in All Children and Adolescents

Published July 17, 2024

Great progress has been made by many countries in reaching the UN 95-95-95 targets for HIV epidemic control, and several countries are approaching or have achieved them. However, children and adolescents living with HIV (CALHIV) consistently fall behind adults in reaching these targets, and the third 95 target of sustained…

Topics:

Pediatric HIV

Countries:

Cameroon,

Eswatini,

Kenya,

Lesotho,

Nigeria,

Republic of the Congo,

Rwanda,

Uganda,

Zambia,

Zimbabwe

Journal Articles

Consistency of Multi-Month Antiretroviral Therapy Dispensing and Association with Viral Load Coverage Among Pediatric Clients Living with HIV in Mozambique

Published June 25, 2024

Abstract With the increase in uptake of multi-month antiretroviral therapy dispensing (MMD) for children, little is known about consistency of MMD receipt over time and its association with virological outcomes. This analysis aims to assess the uptake of 3-month MMD among children, consistent receipt of MMD after uptake, and clinical…

Topics:

Differentiated Service Delivery,

Pediatric HIV,

Research

Countries:

Mozambique

Case Study

The Ariel Club

Published June 12, 2024

Policies and programs to expand access to antiretroviral therapy (ART) in Malawi have made it possible for many infants living with HIV to reach adolescence. However, in most HIV/AIDS treatment facilities, service delivery is more focused on care for adults and children, while the critical needs of adolescents remain largely…

Topics:

Adolescents,

Differentiated Service Delivery

Countries:

Malawi

Journal Articles

Lessons from the Field

Published June 2, 2024

Adolescence is defined by significant socio-emotional changes and vulnerability. Adolescents and youth living with HIV (AYLHIV) experience worse clinical HIV outcomes—adherence, retention and viral load suppression—compared to adults. Novel approaches to implement evidence-based interventions to address their unique needs and life-stage are needed. Undetectable = Untransmittable (U = U) is…

Topics:

Adolescents

Countries:

Lesotho

Technical Briefs

Technical Brief on Paediatric HIV Case-Finding

Published May 6, 2024

Despite global progress in HIV treatment for children, the gap between adult and paediatric treatment coverage continues to widen. This gap is driven primarily by barriers to HIV diagnosis in children, but in the past decade those barriers have shifted. At the start of the epidemic, the lack of access…

Topics:

Pediatric HIV

Journal Articles

Presence of Teen Clubs and its Association with Clinic Attendance among Adolescents Living with HIV in Tanzania

Published April 24, 2024

Introduction Adolescent’s living with Human Immunodeficiency Virus (HIV) are widely reported to have poor adherence to antiretroviral therapy (ART) due to stigma and fear of discrimination. A “Teen club” is an adolescent centered intervention designed to reduce social stigma and improve adherence and retention in HIV care. In this study…

Topics:

Adolescents

Countries:

Tanzania

Journal Articles

Early Effects of Scaling Up Dolutegravir‑Based ARV Regimens Among Children Living with HIV in Malawi

Published April 17, 2024

Viral suppression (VS) in children has remained suboptimal compared to that in adults. We evaluated the impact of transitioning children weighing < 20 kg to a pediatric formulation of dolutegravir (pDTG) on VS in Malawi. We analyzed routine retrospective program data from electronic medical record systems pooled across 169 healthcare…

Topics:

HIV,

Pediatric HIV,

Research

Countries:

Malawi